Kynam Capital Management, LP Portfolio Holdings

Kynam Capital Management, LP

  • $1.22 Billion
  • Q3 2024

Kynam Capital Management, LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $1.22 Billion distributed in 25 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Natera, Inc. with a value of $260M, Vaxcyte, Inc. with a value of $119M, Celldex Therapeutics, Inc. with a value of $117M, Syndax Pharmaceuticals Inc with a value of $112M, and Cogent Biosciences, Inc. with a value of $99.8M.

Examining the 13F form we can see an decrease of $65.7M in the current position value, from $1.28B to 1.22B.

Kynam Capital Management, LP is based out at Princeton, NJ

Below you can find more details about Kynam Capital Management, LP portfolio as well as his latest detailed transactions.

Portfolio value $1.22 Billion
Healthcare: $1.22 Billion

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 25
  • Current Value $1.22 Billion
  • Prior Value $1.28 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 2 stocks
  • Additional Purchases 17 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 4 stocks
Track This Portfolio

Track Kynam Capital Management, LP Portfolio

Follow Kynam Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kynam Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Kynam Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email